Congress
College of American Pathologists Calls on HHS to End FDA Oversight of LDTs
CAP suggested in a letter to HHS that FDA regulation of LDTs conflicts with President Donald Trump's Jan. 31 executive order instructing agencies to reduce regulations.
Consolidation within the industry also remained brisk as cost and reimbursement concerns provided acquisition opportunities for large national outfits.
Top Five Articles on 360Dx Last Week: New LDT Rule Efforts; BARDA Awards to OraSure, InBios; More
Last week, readers were most interested in a story about efforts by a new organization to get Congress to pass legislation revamping oversight of LDTs.
Top Five Articles on 360Dx Last Week: Agilent Reorganizes; Guardant Health Awarded $292.5M; More
Last week, readers were most interested in a story about Agilent changing two of its three business organizations to accelerate growth.
Called the Coalition for Effective Diagnostics, the organization has called on lawmakers to pass legislation revamping diagnostics regulation, including oversight of LDTs.